Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Mallinckrodt
McKesson
Colorcon
Johnson and Johnson

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Mirodenafil


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Mirodenafil?

Mirodenafil is an investigational drug.

There have been 4 clinical trials for Mirodenafil. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2009.

The most common disease conditions in clinical trials are Erectile Dysfunction, Urologic Diseases, and Renal Insufficiency. The leading clinical trial sponsors are SK Chemicals Co., Ltd., SK Chemicals Co.,Ltd., and Asan Medical Center.

Recent Clinical Trials for Mirodenafil
TitleSponsorPhase
Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mgSK Chemicals Co., Ltd.Phase 1
Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mgSK Chemicals Co.,Ltd.Phase 1
Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 50mgSK Chemicals Co., Ltd.Phase 1

See all Mirodenafil clinical trials

Clinical Trial Summary for Mirodenafil

Top disease conditions for Mirodenafil
Top clinical trial sponsors for Mirodenafil

See all Mirodenafil clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Mallinckrodt
McKesson
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.